Intelligent Sexual Health Help System for Gynecologic Cancer Patients
Official title: Intelligent Sexual Health LillyBot Information Support System for Gynecological Cancer Patients: Development, Test and Evaluation of Longitudinal Effects
Run by Chang Gung Memorial Hospital · NCT07794098 · Data updated 2026-11-12
A smartphone-based sexual health education and consultation system called LillyBot will be tested with gynecologic cancer patients to see if it improves sexual well-being.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 70 Years |
| Sex | Women only |
| Enrollment | 90 (estimated) |
| Sponsor | Chang Gung Memorial Hospital Academic / other |
| Locations | 1 site (Taoyuan, Guishan) |
| Status | Recruiting |
| Started | June 17, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07794098 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 20-70 with gynecologic cancer diagnosed within the last six months, undergoing treatment, with a regular partner, and able to use a internet-enabled device, who can read/write Mandarin or Taiwanese.
✕Probably not a fit
Patients without access to internet-enabled devices or who do not engage with digital consultations may see limited or no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial develops and tests LillyBot, an AI-powered chatbot and mobile health tool designed to provide real-time, personalized sexual health information and consultations for gynecologic cancer patients in Taiwan. The project follows a 3-year plan: building a needs assessment and the mHealth-enabled PROM module, designing and developing LillyBot, and then testing it in a prospective pretest-posttest randomized design with three groups. About 90 participants from a northern Taiwan medical center will be recruited and assigned to LillyBot-based consultations, online consultations with sexual health professionals, or online consultations with non-specialists, with data collected at baseline, 1 month, and 3 months to measure outcomes such as sexual distress, knowledge, attitudes, self-efficacy, behaviors, and satisfaction.
Why it matters
Potential benefit: If successful, LillyBot could provide accessible, personalized sexual health support and education for gynecologic cancer patients, potentially improving distress, knowledge, and satisfaction.
How similar studies have gone: Prior research in digital health for cancer-related sexual health shows promise, but this specific AI chatbot, LillyBot, and randomized design for GC patients is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women diagnosed with gynecologic cancer within 6 months prior to enrollment. * Women receiving cancer treatment at the recruiting hospital. * Aged 20 to 70 years, inclusive. * Have a regular partner. * Possesses and is able to use an internet-enabled mobile device (such as a smartphone or iPad). * Able to clearly communicate and read/write in Mandarin or Taiwanese. Exclusion Criteria: * History of other malignant tumors. * Intellectual disability or mental disorders.
Where it's running
-
Cheng Gung Memorial Hospital
Taoyuan, Guishan, Taiwan Recruiting
Study contacts
- Study coordinator: Jian Tao LEE, Professor
- Email: jtlee@gap.cgu.edu.tw
- Phone: 886-03-2118800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Afrocentric Sexual and Reproductive Health Curriculum for Health Professionals in Tanzania
This study tests whether a four-day Afrocentric curriculum for medical, nursing, and midwifery students in Tanzania improves their sexual health knowledge, attitudes, and counseling skills.
-
Mobile health approach to support first-year Ethiopian female students’ sexual health, nutrition, and wellbeing
A mobile health program will test whether monthly app-based education can improve sexual and reproductive health, nutrition, and psychosocial wellbeing among first-year female university students in Ethiopia.
-
Digital PrEP Toolkit to help cisgender women in the Southeast access PrEP
A Digital PrEP Toolkit is being tested to see if it helps cisgender women in Alabama and Mississippi learn about PrEP and start using it.
-
WORTH Paths: digital support for women with substance use and contraception needs
This study tests whether WORTH Paths, a brief digital group program, can help reproductive-aged women involved in the criminal legal system reduce drug use and increase use of contraception.
-
Offering different HIV prevention options to adolescents in Cape Town
This study is testing whether giving young people in Cape Town a choice between three different HIV prevention methods helps them stick with their chosen option better over time.
-
Improving HPV vaccination and adolescent health in Laos
This study is testing if adding HPV vaccinations to health services for young teens in Laos can help more girls get vaccinated and improve their overall health care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.